Fig. 2From: Monitoring the effect of first line treatment in RAS/RAF mutated metastatic colorectal cancer by serial analysis of tumor specific DNA in plasmaOverall survival according to mutational statusThe difference is statistically significant, HR = 2.50, 95%CI = 1.69–3.71, P < 0.001.Tick marks at censor points.Back to article page